Injection of LoVo-AKAP12 cells reduced tumor volume significantly compared with the LoVo-CON and LoVo-LIPO cells four weeks-post injection (p<0.01) (Fig. 3A, B). The gene discussed is HMGA2; the disease is neoplasm.